Pictet Asset Management Holding Sa Halozyme Therapeutics, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88 Billion
- Q3 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 16,954 shares of HALO stock, worth $799,550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,954
Previous 15,495
9.42%
Holding current value
$799,550
Previous $811,000
19.48%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HALO
# of Institutions
543Shares Held
125MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$831 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$608 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$313 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$192 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$161 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $6.57B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...